Loading markets…

Alnylam Pharmaceuticals, Inc. (ALNY) forecast

Alnylam Pharmaceuticals, Inc. (ALNY) forecast: price $228.48, trailing P/E 36.90, forward P/E 34.37. How to read the street's path.

$228.48Price
$30.57BMarket cap
36.90P/E ?
34.37Forward P/E ?
0.00%Dividend yield ?

The live ALNY price is $228.48. Trailing P/E is 36.90 and forward P/E is 34.37. The forecast that matters is the earnings path those ratios imply, not a single target price.

A forward P/E below the trailing P/E means the consensus expects earnings to rise. The reverse means the market is looking at a peak. Neither is a schedule. Analyst targets are useful as a range of models. They are not a contract. Discounted cash flow is the long form: cash flows, a discount rate, and a terminal value you can argue with.

Use this page for the ALNY forecast URL. The prediction page next to it puts the same live inputs in the price-target framing. Both stay in sync with the quote on the main page.

Learn: Forward P/E · Analyst forecast · DCF

Full ALNY quote · Dividends · Price prediction · Academy

Questions

What is ALNY's forward P/E?

The latest forward P/E on Stocklytics is 34.37, against a trailing P/E of 36.90 and a price of $228.48.

Is the analyst target the forecast?

It is one forecast. The earnings estimate behind it is the part you can track. The target will be revised after the next report.